Gastroenterology Search
Gastroenterology Gastroenterology
pancreatitis%20-%20chronic
PANCREATITIS - CHRONIC
Chronic pancreatitis develops from irreversible scarring sustained by the pancreas from prolonged inflammation.
Signs and symptoms include abdominal pain that is epigastric in location that radiates to the back and frequently occurs at night or after meals, symptoms of fat, protein & carbohydrates maldigestion that become apparent with advanced chronic pancreatitis and presence of diarrhea.
Chronic pancreatitis results in destruction of alpha and beta cells which gives rise to deficiencies of both insulin and glucagon.

Pancreatitis - Chronic Drug Information

Drug Information

Indication: Peptic ulcer disease associated w/ H pylori.

Indication: Healing of gastric ulcers associated w/ NSAID therapy. Prevention of gastric & duodenal ulcers associated ...

Indication: Healing & maintenance of erosive or ulcerative GERD. Healing of duodenal ulcers. Pathological hypersecreto...

Indication: Active duodenal, benign gastric, stomal & recurrent ulceration, persistent dyspeptic symptoms w/ or w/o ul...

Indication: Reflux disease & associated symptoms. Prevention of gastroduodenal ulcers induced by NSAIDs in patients at...

Indication: 20 mg: Mild GERD & associated symptoms eg, heartburn, acid regurgitation, pain on swallowing. Long-term ma...

Dosage: Duodenal & benign gastric ulcers 20 mg once daily for 4-8 wk. Dose may be increased to 40 mg once daily in

Indication: Benign gastric & duodenal ulcer, GERD, Zollinger-Ellison syndrome, H pylori eradication.

Indication: Duodenal & benign gastric ulcer, H pylori-associated peptic ulcer, reflux oesophagitis, Zollinger-Ellison ...

Indication: Short-term use for symptomatic improvement & healing of GI diseases requiring GI reduction eg, duodenal &a...

1  /  7
1  /  7
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
What COVID-19 means for IBD care
Pearl Toh, 19 Jan 2021
Updates from the SECURE-IBD* registry reveal that treatment with thiopurine, either alone or in combination with tumour necrosis factor inhibitors (TNFis), for inflammatory bowel disease (IBD) was associated with a greater risk of severe COVID-19 compared with TNFis monotherapy.
Appendicitis likely to occur in children with COVID-19
Stephen Padilla, 2 days ago
Children infected with SARS-CoV-2, the causative agent of the coronavirus disease 2019 (COVID-19), may also develop acute appendicitis, according to a study.
Antibiotics improve disease activity in adults with Crohn’s disease
Audrey Abella, Yesterday
A meta-analysis presented at Crohn’s and Colitis 2021 demonstrated reductions in disease activity among adults with Crohn’s disease (CD) who were taking antibiotics.